The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

Novo Nordisk on Monday reported the oral version of its drug semaglutide reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes by 14% in a large Phase III trial.

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Catalent, a leading contract drug manufacturer, issued an open letter Monday to reassure customers that a proposed $16.5 ...

诺和诺德的GLP-1注射减肥药Wegovy近期因其显著的减肥效果而备受瞩目，而此次165亿美元的收购交易可能会进一步扩大其市场份额。美国公共利益研究小组和服务业雇员国际联盟等组织对此事发出了警告。他们指出，这次交易不仅涉及现有药物，更可能会对未来GLP-1类药物的研发与生产产生深远的影响，尤其是对安进、辉瑞和阿斯利康等竞争对手来说。

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

周四，美国消费者团体和两个大型工会敦促美国联邦贸易委员会 (FTC)阻止 诺和诺德 (NVO.US)股东Novo Holdings收购合同药品制造商Catalent Inc. (CTLT.US)，称该交易威胁到减肥药和尖端基因疗法领域的竞争。

Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research on people ...

诺和诺德与Viatris旗下迈兰制药在一份联合文件中表示，已同意解决与诺和诺德减肥药Ozempic和Wegovy相关的专利纠纷。此前诺和诺德已分别在法院起诉Viatris和其他公司侵犯专利，以阻止拟议的仿制药。诺和诺德发言人当地时间10月7日证实了和解协议。 返回搜狐，查看更多 ...

FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...